Estrella Immunopharma (ESLA) Stock: Buy, Sell, or Hold?
ESLA - Estrella Immunopharma, Inc. Common Stock
$0.47
-0.01 (-1.47%)
▼
5d:
-2.7%
30d:
-32.17%
90d:
-54.12%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When ESLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ESLA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ESLA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ESLA is currently trading at $0.47, which is considered oversold relative to its 30-day fair value range of $0.49 to $0.69.
Technical Outlook: Technically, ESLA is in a strong downtrend. Immediate support is located at $0.43, while resistance sits at $0.58.
Market Sentiment: ESLA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+2464.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ESLA is in a strong downtrend. Immediate support is located at $0.43, while resistance sits at $0.58.
Market Sentiment: ESLA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+2464.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.49 -
$0.69
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2464.1% below Wall St target ($12.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.49 -
$0.69
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.43
Resistance Level
$0.58
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.46
Wall Street Target
$12.00
(+2464.1%)
Share & Embed Analysis
Last updated: October 03, 2026 10:38 PM ET
Data refreshes hourly during market hours. Next update: 11:38 PM
Data refreshes hourly during market hours. Next update: 11:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ESLA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
